EOLS

SEC source: 0001570562-23-000022 · wf-form4_167521567128262.xml · derivative · entry 3

BLANK SIMONE · CIK 0001366840 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,789

Underlying: Common Stock · 11,789 shares

Expires 2033-01-27

F3 · derivative.exercise_date: The shares subject to the option will vest over a period of twelve months, with 1/12th of the shares subject to the option vesting monthly on the anniversary of January 27, 2023, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

SEC source: 0001570562-23-000022 · wf-form4_167521567128262.xml · nonDerivative · entry 1

BLANK SIMONE · CIK 0001366840 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,174

F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of January 27, 2023, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer.

SEC source: 0001570562-23-000026 · wf-form4_167521574831474.xml · derivative · entry 2

Stewart Brady · CIK 0001902893 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,789

Underlying: Common Stock · 11,789 shares

Expires 2033-01-27

F2 · derivative.exercise_date: The shares subject to the option will vest over a period of twelve months, with 1/12th of the shares subject to the option vesting monthly on the anniversary of January 27, 2023, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

SEC source: 0001570562-23-000026 · wf-form4_167521574831474.xml · nonDerivative · entry 1

Stewart Brady · CIK 0001902893 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,801

F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of January 27, 2023, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer.

SEC source: 0001570562-23-000024 · wf-form4_167521570855640.xml · derivative · entry 3

Malik Vikram · CIK 0001730123 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,789

Underlying: Common Stock · 11,789 shares

Expires 2033-01-27

F3 · derivative.exercise_date: The shares subject to the option will vest over a period of twelve months, with 1/12th of the shares subject to the option vesting monthly on the anniversary of January 27, 2023, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

SEC source: 0001570562-23-000024 · wf-form4_167521570855640.xml · nonDerivative · entry 1

Malik Vikram · CIK 0001730123 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,585

F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of January 27, 2023, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer.

SEC source: 0001570562-23-000023 · wf-form4_167521568896760.xml · derivative · entry 2

Parschauer Karah Herdman · CIK 0001677455 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,789

Underlying: Common Stock · 11,789 shares

Expires 2033-01-27

F2 · derivative.exercise_date: The shares subject to the option will vest over a period of twelve months, with 1/12th of the shares subject to the option vesting monthly on the anniversary of January 27, 2023, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

SEC source: 0001570562-23-000023 · wf-form4_167521568896760.xml · nonDerivative · entry 1

Parschauer Karah Herdman · CIK 0001677455 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,174

F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of January 27, 2023, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer.

SEC source: 0001570562-23-000010 · wf-form4_167486545975097.xml · derivative · entry 2

Beaver Sandra · CIK 0001944884 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,670

Underlying: Common Stock · 85,670 shares

Expires 2033-01-25

F2 · derivative.exercise_date: The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of January 25, 2023, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

SEC source: 0001570562-23-000010 · wf-form4_167486545975097.xml · nonDerivative · entry 1

Beaver Sandra · CIK 0001944884 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,085

F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of January 25, 2023, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

SEC source: 0001570562-23-000012 · wf-form4_167486549856245.xml · derivative · entry 2

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,670

Underlying: Common Stock · 85,670 shares

Expires 2033-01-25

F2 · derivative.exercise_date: The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of January 25, 2023, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

SEC source: 0001570562-23-000012 · wf-form4_167486549856245.xml · nonDerivative · entry 1

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 350,831

F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of January 25, 2023, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

SEC source: 0001570562-23-000011 · wf-form4_167486547956707.xml · derivative · entry 2

MOATAZEDI DAVID · CIK 0001700836 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 257,009

Underlying: Common Stock · 257,009 shares

Expires 2033-01-25

F2 · derivative.exercise_date: The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of January 25, 2023, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

SEC source: 0001570562-23-000011 · wf-form4_167486547956707.xml · nonDerivative · entry 1

MOATAZEDI DAVID · CIK 0001700836 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 679,888

F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of January 25, 2023, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

SEC source: 0001387131-23-001468 · ownership.xml · nonDerivative · entry 3

Medytox Inc. · CIK 0001848514 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 7,259,500

F1 · date: Inadvertently filed late due to an administrative error.

F4 · ownership.nature: The Issuer shares were previously held of record by Medytox Korea Co., Ltd. ("Medytox Korea"). Medytox, Inc. owns 100% of Medytox Korea. Accordingly, Medytox, Inc. may be deemed to beneficially own indirectly the shares by reason of Medytox Korea's direct beneficial ownership.

SEC source: 0001387131-22-010336 · eols-form4_100622.xml · nonDerivative · entry 1

Medytox Inc. · CIK 0001848514 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,259,500

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.95 to $9.02, inclusive. The reporting person undertakes to provide to Evolus, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001839882-22-023112 · eols-form4_100522.xml · nonDerivative · entry 1

Medytox Inc. · CIK 0001848514 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,297,804

SEC source: 0001387131-22-009830 · eols-form4_091422.xml · nonDerivative · entry 2

Medytox Inc. · CIK 0001848514 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,304,652

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.17 to $10.43, inclusive.

SEC source: 0001387131-22-009830 · eols-form4_091422.xml · nonDerivative · entry 1

Medytox Inc. · CIK 0001848514 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,328,652

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.10 to $10.54, inclusive. The reporting person undertakes to provide to Evolus, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnotes (1) and (2) to this Form 4.

SEC source: 0001570562-22-000136 · wf-form4_166310623494673.xml · nonDerivative · entry 2

HAYMAN ROBERT · CIK 0001269349 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By trust

Disclosed balance after: 10,000

F2 · ownership.nature: By the Robert Hayman Living Trust

SEC source: 0001387131-22-009717 · eols-form4_090822.xml · nonDerivative · entry 2

Medytox Inc. · CIK 0001848514 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,401,652

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.45 to $10.70, inclusive.

SEC source: 0001570562-22-000136 · wf-form4_166310623494673.xml · nonDerivative · entry 1

HAYMAN ROBERT · CIK 0001269349 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By trust

Disclosed balance after: 8,909

F1 · price: The shares were purchased in multiple trades at prices ranging from $10.335 to $10.35. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2 · ownership.nature: By the Robert Hayman Living Trust

SEC source: 0001387131-22-009717 · eols-form4_090822.xml · nonDerivative · entry 1

Medytox Inc. · CIK 0001848514 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,422,352

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.34 to $10.50, inclusive. The reporting person undertakes to provide to Evolus, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form4.

SEC source: 0001570562-22-000132 · wf-form4_166275726389372.xml · nonDerivative · entry 1

HAYMAN ROBERT · CIK 0001269349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,848

F1 · balance_after: Total includes 15,568 shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of January 24, 2022, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer.

SEC source: 0001570562-22-000135 · wf-form4a_166310621745989.xml · nonDerivative · entry 1

HAYMAN ROBERT · CIK 0001269349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,881

F1 · balance_after: Total includes 15,568 shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of January 24, 2022, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer.

SEC source: 0001570562-22-000127 · wf-form4_166250899349421.xml · nonDerivative · entry 1

FARRELL PETER C · CIK 0001186102 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By trust

Disclosed balance after: 10,000

F1 · price: The shares were purchased in multiple trades at prices ranging from $9.02 to $9.18. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2 · ownership.nature: By Peter C. Farrell Trust

SEC source: 0001570562-22-000128 · wf-form4_166264373900205.xml · nonDerivative · entry 1

BLANK SIMONE · CIK 0001366840 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,881

F1 · price: The shares were purchased in multiple trades at prices ranging from $9.08 to $9.52. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2 · balance_after: Total includes 15,568 shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of January 24, 2022, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer.

SEC source: 0001570562-22-000125 · wf-form4_166249851366040.xml · derivative · entry 2

Beaver Sandra · CIK 0001944884 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 169,158

Underlying: Common Stock · 169,158 shares

Expires 2032-09-05

F2 · derivative.exercise_date: The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of September 5, 2022, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

SEC source: 0001570562-22-000125 · wf-form4_166249851366040.xml · nonDerivative · entry 1

Beaver Sandra · CIK 0001944884 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,443

F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of September 5, 2022, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

SEC source: 0001387131-22-008344 · eols-form4_082721.xml · nonDerivative · entry 1

Medytox Inc. · CIK 0001848514 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,437,652

SEC source: 0001570562-22-000107 · wf-form4_165291965473241.xml · nonDerivative · entry 2

SILVERNAIL LAUREN P · CIK 0001225755 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 141,571

F2 · price: The shares were sold in multiple trades at prices ranging from $12.15 to $13.515. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001570562-22-000107 · wf-form4_165291965473241.xml · nonDerivative · entry 1

SILVERNAIL LAUREN P · CIK 0001225755 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 193,586

F1 · price: The shares were sold in multiple trades at prices ranging from $13.90 to $14.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001570562-22-000104 · wf-form4_165282765366364.xml · nonDerivative · entry 2

GILL DAVID N · CIK 0001106519 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,568

F2 · price: The shares were sold in multiple trades at prices ranging from $13.50 to $13.79. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001570562-22-000108 · wf-form4_165291968277127.xml · nonDerivative · entry 1

MOATAZEDI DAVID · CIK 0001700836 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 491,961

F1 · price: The shares were sold in multiple trades at prices ranging from $13.49 to $13.78. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001570562-22-000104 · wf-form4_165282765366364.xml · nonDerivative · entry 1

GILL DAVID N · CIK 0001106519 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,568

F1 · price: The shares were sold in multiple trades at prices ranging from $13.07 to $13.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001570562-22-000088 · wf-form4_164868132773826.xml · nonDerivative · entry 1

MOATAZEDI DAVID · CIK 0001700836 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 547,282

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain Restricted Stock Units.

SEC source: 0001570562-22-000084 · wf-form4_164695819801702.xml · nonDerivative · entry 1

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 253,189

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain Restricted Stock Units.

F2 · price: The shares were sold in multiple trades at prices ranging from $9.50 to $9.87. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001570562-22-000083 · wf-form4_164695816288187.xml · nonDerivative · entry 1

SILVERNAIL LAUREN P · CIK 0001225755 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 209,775

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain Restricted Stock Units.

F2 · price: The shares were sold in multiple trades at prices ranging from $9.50 to $9.87. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001570562-22-000086 · wf-form4_164695825989570.xml · nonDerivative · entry 1

Muilenburg Crystal · CIK 0001848477 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,248

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain Restricted Stock Units.

F2 · price: The shares were sold in multiple trades at prices ranging from $9.50 to $9.87. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001570562-22-000085 · wf-form4_164695823489876.xml · nonDerivative · entry 1

MOATAZEDI DAVID · CIK 0001700836 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 553,386

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain Restricted Stock Units.

F2 · price: The shares were sold in multiple trades at prices ranging from $9.50 to $9.87. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001570562-22-000049 · wf-form4_164324887745959.xml · derivative · entry 2

GILL DAVID N · CIK 0001106519 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,727

Underlying: Common Stock · 22,727 shares

Expires 2032-01-24

F2 · derivative.exercise_date: The shares subject to the option will vest as to 1/12 of the underlying shares monthly from the vesting commencement date of January 24, 2022, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

SEC source: 0001570562-22-000049 · wf-form4_164324887745959.xml · nonDerivative · entry 1

GILL DAVID N · CIK 0001106519 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,881

F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of January 24, 2022, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer

SEC source: 0001570562-22-000053 · wf-form4_164324895584499.xml · derivative · entry 2

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,640

Underlying: Common Stock · 77,640 shares

Expires 2032-01-25

F2 · derivative.exercise_date: The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of January 24, 2022, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

SEC source: 0001570562-22-000053 · wf-form4_164324895584499.xml · nonDerivative · entry 1

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 263,381

F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of January 24, 2022, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

SEC source: 0001570562-22-000052 · wf-form4_164324893655076.xml · derivative · entry 2

Muilenburg Crystal · CIK 0001848477 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,464

Underlying: Common Stock · 72,464 shares

Expires 2032-01-25

F2 · derivative.exercise_date: The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of January 24, 2022, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

SEC source: 0001570562-22-000052 · wf-form4_164324893655076.xml · nonDerivative · entry 1

Muilenburg Crystal · CIK 0001848477 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,743

F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of January 24, 2022, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

SEC source: 0001570562-22-000047 · wf-form4_164324883737088.xml · derivative · entry 2

HAYMAN ROBERT · CIK 0001269349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,727

Underlying: Common Stock · 22,727 shares

Expires 2032-01-24

F2 · derivative.exercise_date: The shares subject to the option will vest as to 1/12 of the underlying shares monthly from the vesting commencement date of January 24, 2022, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

SEC source: 0001570562-22-000047 · wf-form4_164324883737088.xml · nonDerivative · entry 1

HAYMAN ROBERT · CIK 0001269349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,881

F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of January 24, 2022, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer

SEC source: 0001570562-22-000048 · wf-form4_164324885895783.xml · derivative · entry 2

FARRELL PETER C · CIK 0001186102 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,727

Underlying: Common Stock · 22,727 shares

Expires 2032-01-24

F2 · derivative.exercise_date: The shares subject to the option will vest as to 1/12 of the underlying shares monthly from the vesting commencement date of January 24, 2022, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

SEC source: 0001570562-22-000048 · wf-form4_164324885895783.xml · nonDerivative · entry 1

FARRELL PETER C · CIK 0001186102 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,881

F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of January 24, 2022, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer